Drug & intervention

hydrochlorothiazide

RxCUI 5487

Clinical trials60
Recruiting1
Related conditions20
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…
Background context

Hydrochlorothiazide

Hydrochlorothiazide, sold under the brand name Hydrodiuril among others, is a diuretic medication used to treat hypertension and swelling due to fluid build-up. Other uses include treating diabetes insipidus and renal tubular acidosis and to decrease the risk of kidney stones in hypercalciuria. Hydrochlorothiazide is taken by mouth and may be combined with other blood pressure medications as a single pill to increase effectiveness. Hydrochlorothiazide is a thiazide medication which inhibits reabsorption of sodium and chloride ions from the distal convoluted tubules of the kidneys, causing a natriuresis. This initially increases urine volume and lowers blood volume. It is believed to reduce peripheral vascular resistance. Potential side effects include poor kidney function, electrolyte imbalances, including low blood potassium, and, less commonly, low blood sodium, gout, high blood sugar, and feeling lightheaded with standing. Two companies, Merck & Co. and Ciba Specialty Chemicals, state they discovered the medication which became commercially available in 1959. It is on the World Health Organization's List of Essential Medicines. It is available as a generic drug and is relatively affordable. In 2023, it was the sixteenth most commonly prescribed medication in the United States, with more than 31 million prescriptions.

Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

40 shown
Bariatric Surgery and Pharmacokinetics of HydrochlorothiazideNCT03476551 · 2016-11-02
RECRUITING
Multi-Omics to Predict the Blood Pressure Response to AntihypertensivesNCT05917275 · 2024-04-04
UNKNOWN
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Dihydropyridine Calcium Channel Blockers Versus HydrochlorothiazideNCT05125224 · 2021-10-01
COMPLETED
Sympathetic Regulation of Large Artery Stiffness in Humans With ISHNCT04423627 · 2021-06-01
COMPLETED
Hydrochlorothiazide and Risk of Skin CancerNCT04334824 · 2019-05-27
COMPLETED
N-of-1 Trials In Children With HypertensionNCT03461003 · 2018-04-02
COMPLETED
A Drug to Drug Interaction Study of Sotagliflozin With HydrochlorothiazideNCT03387657 · 2018-01-03
COMPLETED
Anxiety-mediated Impairments in Large Elastic Artery Function and the Autonomic Nervous SystemNCT03109795 · 2017-04-10
TERMINATED
EBMtrialcentral- Comparing Initial Diuretic Therapies Using a Collaborative NetworkNCT01748123 · 2016-08-01
WITHDRAWN
Peripheral Vascular Effects of Sulfhydryl-containing Antihypertensive Pharmacotherapy on Microvessels in HumansNCT03179163 · 2016-07-20
TERMINATED
Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With HypertensionNCT02646397 · 2016-02-01
UNKNOWN
Aliskiren Study of Safety and Efficacy in Senior HypertensivesNCT01922141 · 2015-05-01
WITHDRAWN
RAS Peptide Profiles in Patients With Arterial HypertensionNCT02449811 · 2015-04-01
COMPLETED
Treatment of OSA Associated Hypertension With Nebivolol or HydrochlorothiazideNCT02710071 · 2015-01-01
COMPLETED
Treatment of OSA Associated Hypertension With Alpha 2 Agonist or DiureticNCT02699125 · 2015-01-01
COMPLETED
Telmisartan and Hydrochlorothiazide Antihypertensive Treatment Study in High Sodium Intake PopulationNCT02255253 · 2014-10-01
COMPLETED
A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/HydrochlorothiazideNCT02222480 · 2014-10-01
COMPLETED
INTERVENCION TrialNCT02373163 · 2014-09-01
COMPLETED
Treatment of Hypertension in Tibetan Adult PopulationNCT02217852 · 2014-08-01
UNKNOWN
N-of-1 Trials for Blood Pressure Medications in AdultsNCT02744456 · 2014-08-01
COMPLETED
Add-on to Micamlo BP TrialNCT01975246 · 2013-11-01
COMPLETED
Vascular Dysfunction in Human Obesity HypertensionNCT01983462 · 2013-10-01
TERMINATED
Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential HypertensionNCT02412761 · 2013-06-01
COMPLETED
Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.NCT02072330 · 2013-03-01
COMPLETED
Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With HypertensionNCT01692301 · 2012-12-01
COMPLETED
A Pilot Study of Plasma Renin Activity Guided vs Generic Combination Therapy for HypertensionNCT01658657 · 2012-10-01
COMPLETED
Aliskiren vs Hydrochlorothiazide in Hypertensive Type II Diabetic Patients on Resistance ArteriesNCT01480791 · 2012-01-01
WITHDRAWN
Effect of Aliskiren and Hydrochlorothiazide on Kidney Oxygenation in Patients With HypertensionNCT01519635 · 2011-10-01
COMPLETED
Safety and Tolerability of Valsartan in Children 6 to 17 Years of AgeNCT01365481 · 2011-08-01
COMPLETED
Pharmacodynamics and Pharmacokinetics of Empagliflozin and Torasemide in Patients With Type 2 DiabetesNCT01276288 · 2011-01-01
COMPLETED
Hypertensive Ambulatory Trial to Compare the Efficacy of HCTZ and LisinoprilNCT01258764 · 2010-11-01
COMPLETED
Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal InsufficiencyNCT01172431 · 2010-09-01
COMPLETED
Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 DiabetesNCT00976495 · 2009-10-01
COMPLETED
Evaluating the Effect of Aliskiren Versus HCTZ on Coronary Flow Reserve in Hypertensive Type II DiabeticsNCT00994253 · 2009-08-01
WITHDRAWN
Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe HypertensionNCT00926289 · 2009-06-01
COMPLETED
Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate HypertensionNCT00765947 · 2008-09-01
COMPLETED
A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Participants With Essential HypertensionNCT00667719 · 2008-06-05
COMPLETED
Safety and Efficacy Study of a Triple Combination Therapy in Subjects With HypertensionNCT00649389 · 2008-05-01
COMPLETED
The Antihypertensives and Vascular, Endothelial and Cognitive Function TrialNCT00605072 · 2008-01-01
COMPLETED
Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled HypertensionNCT00523744 · 2007-07-01
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.